Positive Impact

Premium coloured contact lenses designed for professional eye care.

A Premium Opportunity

Coloured contact lenses remain a recognised premium category within eye care, yet many practices now offer them only when patients ask.


ATTITUDE coloured contact lenses from Desio provides a fresh opportunity to proactively introduce colour lenses through a professional colour consultation experience that can attract new patients, engage existing wearers, and generate incremental revenue.


Suitable for occasional wear, lifestyle enhancement or everyday confidence, ATTITUDE creates new conversations around contact lenses whilst remaining firmly within professional eye care.

Introducing

The ATTITUDE Colour Experience

Why Practices Choose ATTITUDE

Daily & Monthly Modalities

Extensive Prescription Availability

Extended Parameters

Toric Options

Sutable for Occasional or regular wear

ATTITUDE

The Collection

Desio ATTITUDE lenses are available in plano or prescription versions to correct myopia, hyperopia, and even astigmatism.

Want to find out more?

Whether you’d like to learn more about the DESIO ATTITUDE collection, discuss how to introduce a successful Colour Experience into your practice, or arrange tailored training for your team, we’re here to help.

Interested in offering ATTITUDE in your practice?

Contact us to find out more about Desio lenses and get fitting in practice.

T: 01424 851 375

Read the news on our
contact lenses range

NaturalVue® takes home the Contact Lens Award

Positive Impact, in partnership with Visioneering Technologies, Inc. (VTI), has won The Contact Lens Award at the prestigious Optician Awards 2024 for its NaturalVue® Enhanced Multifocal 1 Day contact lens.

Learn More
Two choices with easy empirical fitting

Positive Impact (PI) has launched two new contact lenses in the UK, Alexa high resolution AR, offering a new concept in Ortho-K and Esencia, which is CE-marked for myopia control.

Learn More
NEW NaturalVue® RCT Data

VTI Announces Positive Interim 1-Year Data from the PROTECT Clinical Trial for Myopia Progression Control at the American Academy of Optometry Annual Meeting

Learn More